
Richard White lieutenant Zubin Appoo lands CEO role at WiseTech Global
Current chief of staff Zubin Appoo will succeed interim boss Andrew Cartledge, who was pushed into the role last October after Mr White gave up the job amid a series of damning allegations and a board investigation into his relationship with employees.
There were also allegations that he used his influence to gain sexual favours, and paid for a multimillion-dollar house for an employee he had been in a relationship with.
Mr White sensationally regained control of WiseTech in February as executive chair, despite the board investigation finding he failed to fully disclose personal relationships with employees.
His return was preceded by the departure of four independent directors who had voiced concern about his ongoing influence over the $33.5 billion listed company.
Mr Appoo previously worked at the company between 2004 and 2018 as head of innovation and technology, working closely with Mr White, and rejoined the ranks in April.
In an announcement to the Australian Securities Exchange on Monday, WiseTech said he was a proven technology leader with an extensive understanding of WiseTech's business, which develops software solutions for global supply chains and logistics firms.
It has a current customer base of 16,500 and in May announced a $3.3b deal to fund expansion in the US through the acquisition of Texas-based e2open — the biggest ever deal in the company's 30-year history.
'He will collaborate with and support co-founder and executive chair, Richard White, with long-term product vision, innovation and strategic investment,' the statement said.
'The appointment of Zubin reinforces the board's commitment to robust governance and clarity of executive roles.
'This leadership model ensures the complementary strengths of both our executive chair and CEO are fully harnessed — with the CEO accountable to the board for operational performance and strategic execution.
'This clarity will serve our people, customers, partners, and investors well.'
Mr Appoo will have 'full accountability for the performance and growth of the business, including leadership across operations, people, culture, product delivery and commercial performance'.
Lead independent director Andrew Harrison said Mr Appoo would bring to the role a strong software and product development background along with 'knowledge of WiseTech's products, markets and methods'.
Mr Harrison also said he would 'seamlessly partner with our co-founder and executive chair, while also operating independently and decisively as CEO'.
Mr White said WiseTech needed a strong succession plan in place as the company plots its next phase of growth.
'Since rejoining WiseTech as chief of staff, Zubin has been working closely with our senior leadership team, our development teams, as well as customers, and investors,' he said.
'He has immersed himself in WiseTech's business operations with a focus on driving innovation, value creation, and efficiencies.'
Mr Appoo will start on a base annual salary of $700,000 with a remuneration equity grant of $700,000 a year delivered in the form of share rights.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

AU Financial Review
6 minutes ago
- AU Financial Review
WiseTech's new CEO sucks up to the top
WiseTech's Richard White caused another ripple in the market first thing on Monday by announcing the company's new permanent CEO would be Zubin Appoo. It's not just that the 44-year-old has never been a chief executive of an ASX-listed firm, or as our sister column Chanticleer pointed out, his last role was with a church-affiliated carer website, but Appoo only recently returned to the company where he last worked in 2018.

The Age
an hour ago
- The Age
Strategic CEO hire to drive NeuroScientific stem cell therapy release
NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment in less than a week, bringing in experienced Melbourne-based executive Nathan Smith as its chief executive officer, as the company gears up for the commercial release of its innovative StemSmart stem cell technology. Smith has extensive experience in cell and gene therapies in senior commercial, operational and strategic roles in Australia and the United States, which should prove invaluable as the company navigates the regulatory and commercial pathways for its innovative StemSmart technology. The company says his deep expertise in good practice manufacturing will be critical for converting the biotechnology startup into a scaled-up commercial stem cell company. NeuroScientific acquired the StemSmart technology in late June via its $4.1 million acquisition of unlisted Perth-based stem cell company Isopgen. StemSmart uses a specific type of stem cell, mesenchymal stromal stem cells (MSC), as a last-line infusion treatment for critically ill patients, including those experiencing severe immune complications from bone marrow transplants, kidney and lung transplant rejection and inflammatory Crohn's disease. 'I was attracted to NSB given the historical success of StemSmart in multiple serious clinical disorders and the clear potential of the technology for further development.' NeuroScientific Biopharmaceuticals chief executive officer Nathan Smith Adding to the company's ranks of highly credentialled personnel, NeuroScientific announced on Friday that it had also recruited well-regarded Perth-based paediatric haematologist and oncologist Dr Catherine Cole as its chief medical officer. The news of both appointments has continued to fuel a stellar rise in the company's share price, which traded 11.3 per cent higher today to 24.5 cents on the best turnover since April. The company's share price is up 360 per cent since the start of June. Smith was the director of business development at Melbourne's Cell Therapies, which develops and manufactures advanced cell-based therapies and is located within the city's pioneering Peter MacCallum Cancer Centre. He has held key roles at Genzyme Corporation, Mesoblast Inc and GlaxoSmithKline in the US, as well as other leading companies in the cell therapy sector.


7NEWS
an hour ago
- 7NEWS
Ansett Australia revived as AI-powered travel platform two decades after carrier's collapse
The Ansett name 'is back', but not as Australians will remember the former airline. Ansett Australia was once the country's second-largest carrier but collapsed into administration after suffering financial troubles in 2001. Its final flight was recorded early the following year. Now, more than 20 years later, the brand is being revived not as an airline but as an AI-powered holiday booking platform called Ansett Travel. Melbourne-based entrepreneur Constantine Frantzeskos said it was designed to be a 'hyper-personalised' travel agent that suggests trips and itineraries based on your preferences, calendar events and budgets. 'I didn't just acquire a lapsed trademark and domain, I resurrected trust embedded deep in collective memory,' Frantzeskos said on Monday. 'The original Ansett served Australians beautifully for 65 years before collapsing in 2002, leaving a void in reliability and brand warmth. 'I believe that legacy still matters, and that it's deserving of being reimagined for modern travellers. 'Ansett Travel isn't about replicating the past, it's about re‑engineering it through AI as the core, not as an afterthought.' What Ansett Travel will offer Frantzeskos has previously worked with Emirates, Dubai Tourism and Visit Victoria, and this time partnered with Victorian travel start-up Travlr. He said the new platform is 'like the Costco of travel'. It is open to everyone 'but if you want the really good stuff' — flights, hotels and holidays at near-wholesale prices — you will need to join Ansett VIP, he said. An Ansett VIP membership is $99 a year. Not all AI features are up and running but Frantzeskos said plans for things like auto-generated itineraries, pre-trip alerts, and personalised loyalty experiences are on the cards. 'Today's travel platforms are reactive,' he said. 'You search, compare, click. Ansett seeks to flip that model. 'It's designed to anticipate when users need a break – school holidays, anniversaries, executive downtime, great weather for a weekend away – and offer options before you even think to ask. 'It's not replacing human agents; it's doing what scale, data and logic do best – with finesse, not friction.' The website is already live and offering travel deals for destinations including Las Vegas, Bali, Tokyo and Athens. Before its collapse, Ansett reportedly flew about 10 million passengers annually. More than 16,000 jobs were lost as a result of the company's downfall.